Table 2.

Medical therapy regarding the four pillars for heart failure at 6 months follow up according to each group

Therapy	Group 1 (N= 139)	Group 2 (N=139)	p value
BB, n (%)	136 (98)	135 (97.6)	1
ARNI, n (%)	126 (91)	51 (36.5)	< 0.001
ACEi/ARBs, n (%)	0 (0)	66 (47.2)	< 0.001
SGLT2i, n (%)	124 (89)	126 (91)	0.84
MRAs, n (%)	115 (83)	114 (82)	1

For patients who experienced cardiovascular death within the study period, the medical therapy at the moment of the adverse event has been recorded

ACEi angiotensin-converting enzyme inhibitors, ARBs angiotensin receptor blockers, ARNI angiontensin receptor neprilysin inhibitors, BB beta blockers, MRAs mineralcorticoid receptor antagonists, SGLT2i sodium-glucose co-transporter-2 inhibitors.